Teaching physicians cultural competency concepts and skills that will help them overcome the challenge of caring for patients from many cultures and lead to improved patient-physician communication.
New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Physicians need to exhaust every possible alternative to bring about political changes before resorting to breaking the law as an act of civil disobedience.
Physicians need to exhaust every possible alternative to bring about political changes before resorting to breaking the law as an act of civil disobedience.
Physicians need to perform their due diligence and practice caution when prescribing addictive pain medications to relieve their patients' chronic pain due to increased federal monitoring of pain prescriptions.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.